{"name": "Pharma Two B",
 "permalink": "pharma-two-b",
 "crunchbase_url": "http://www.crunchbase.com/company/pharma-two-b",
 "homepage_url": "http://www.pharma2b.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "972-8- 9472672",
 "description": "",
 "created_at": "Tue Oct 23 05:48:11 UTC 2012",
 "updated_at": "Tue Mar 26 07:27:46 UTC 2013",
 "overview": "\u003Cp\u003EPharma Two B develops clinically differentiated and value-added products, based on approved drugs. They focus on Fixed-Dose-combinations of two or more drugs with complementary and synergistic effects, providing high clinical value and shorter regulatory pathways (US 505b2 approach). The company develops products in two therapeutic areas with great unmet needs - Parkinson\u0026#8217;s disease (PD) and Cancer.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       50],
      "assets/images/resized/0021/6764/216764v1-max-150x150.jpg"],
     [[250,
       83],
      "assets/images/resized/0021/6764/216764v1-max-250x250.jpg"],
     [[268,
       90],
      "assets/images/resized/0021/6764/216764v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "CEO",
    "person":
     {"first_name": "Nurit",
      "last_name": "Livnah",
      "permalink": "nurit-livnah",
      "image": null}},
   {"is_past": false,
    "title": "CFO",
    "person":
     {"first_name": "Irit",
      "last_name": "Zalayet",
      "permalink": "irit-zalayet",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$8M",
 "funding_rounds":
  [{"round_code": "b",
    "source_url": "http://www.finsmes.com/2012/10/pharma-completes-8m-financing.html?utm_source=feedburner\u0026utm_medium=feed\u0026utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29",
    "source_description": "Pharma Two B Completes $8M Second Financing Round",
    "raised_amount": 8000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2012,
    "funded_month": 10,
    "funded_day": 23,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "JK\u0026B Capital",
         "permalink": "jk-b-capital",
         "image":
          {"available_sizes":
            [[[150,
               67],
              "assets/images/resized/0004/4272/44272v1-max-150x150.png"],
             [[210,
               95],
              "assets/images/resized/0004/4272/44272v1-max-250x250.png"],
             [[210,
               95],
              "assets/images/resized/0004/4272/44272v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org": null,
       "person":
        {"first_name": "Michael",
         "last_name": "Mittelman",
         "permalink": "michael-mittelman",
         "image": null}}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "3 Pekeris Street",
    "address2": "Weizmann Science Park",
    "zip_code": "76702",
    "city": "Rehovot",
    "state_code": null,
    "country_code": "ISR",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        122],
       "assets/images/resized/0021/6765/216765v1-max-150x150.jpg"],
      [[250,
        204],
       "assets/images/resized/0021/6765/216765v1-max-250x250.jpg"],
      [[450,
        368],
       "assets/images/resized/0021/6765/216765v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}